Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Treatment Naive”

1,088 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 1,088 results

Not applicableStudy completedNCT01726439
What this trial is testing

Effectiveness of Nucleos(t)Ide Analogs (NUC) Therapy Among Naive CHB Patients in China

Who this might be right for
Chronic Hepatitis B
Bristol-Myers Squibb 3,434
Post-approval studies (Phase 4)Study completedNCT00653302
What this trial is testing

Phenotype Evaluation in Insulin Naive Patients Using Lantus (Insulin Glargine)

Who this might be right for
Type 2 Diabetes
Sanofi 280
Testing effectiveness (Phase 2)UnknownNCT00703872
What this trial is testing

HDV-Interferon in the Treatment of Chronic Hepatitis C Nonresponders and Naive Hepatitis C Patients

Who this might be right for
Chronic Hepatitis C
Hepasome Pharmaceuticals 50
Testing effectiveness (Phase 2)Study completedNCT04439539
What this trial is testing

JNJ-73763989, Pegylated Interferon Alpha-2a, Nucleos(t)Ide Analog (NA) With or Without JNJ-56136379 in Treatment-naive Participants With Hepatitis B e Antigen (HBeAg) Positive Chronic Hepatitis B Virus (HBV) Infection

Who this might be right for
Hepatitis B, Chronic
Janssen Research & Development, LLC 54
Not applicableStudy completedNCT01333644
What this trial is testing

The Role of Inflammation and Aging in HIV-Associated Cardiovascular Risk

Who this might be right for
HIV InfectionCardiovascular DiseaseInflammation
University of California, San Francisco 270
Post-approval studies (Phase 4)Study completedNCT00192621
What this trial is testing

Seronegatives and Metabolic Abnormalities Protocol 2 (SAMA002): Study to Compare the Effect of Kaletra and Combivir® in HIV-Negative Healthy Subjects

Who this might be right for
HIV InfectionsDyslipidemiasGlucose Metabolism Disorders+3 more
Kirby Institute 50
Large-scale testing (Phase 3)UnknownNCT00761111
What this trial is testing

Could a Simple Information Booklet Modify Low Back Pain Patients Beliefs After Lumbar Discectomy?

Who this might be right for
Back Pain
University Hospital, Clermont-Ferrand 140
Large-scale testing (Phase 3)Study completedNCT01363011
What this trial is testing

Cobicistat-containing Highly Active Antiretroviral Regimens in HIV-1 Infected Patients With Mild to Moderate Renal Impairment

Who this might be right for
Acquired Immunodeficiency SyndromeHIV Infections
Gilead Sciences 106
Testing effectiveness (Phase 2)Study completedNCT00084084
What this trial is testing

Replagal Enzyme Replacement Therapy for Children With Fabry Disease

Who this might be right for
Fabry Disease
Shire 17
Post-approval studies (Phase 4)Study completedNCT04880395
What this trial is testing

Dolutegravir-Lamivudine for naïve HIV-Infected Patients With ≤200 CD4/mm3

Who this might be right for
HIV-1-infection
Fundación Huésped 265
Not applicableStudy completedNCT00929604
What this trial is testing

HIV Viral Load Monitoring in Resource-Poor Settings

Who this might be right for
HIVAIDSHIV Infections
University of Alabama at Birmingham 2,112
Testing effectiveness (Phase 2)Study completedNCT02413593
What this trial is testing

Safety and Efficacy of Ledipasvir/Sofosbuvir (LDV/SOF) Fixed Dose Combination Tablet With Ribavirin for 12 Weeks in Treatment-naive Adults With Chronic HCV Genotype 3 Infection

Who this might be right for
Hepatitis C Virus Infection
Gilead Sciences 111
Post-approval studies (Phase 4)Study completedNCT02557100
What this trial is testing

Study to Assess Changes in the Immune Profile in Adults With Early Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Bristol-Myers Squibb 80
Not applicableStudy completedNCT00260936
What this trial is testing

Metabolic Abnormalities - HIV Infected and Uninfected Males

Who this might be right for
HIV Infections
University of North Carolina, Chapel Hill 250
Large-scale testing (Phase 3)Study completedNCT06799546
What this trial is testing

A Phase III Study to Evaluate the Efficacy and Safety of HSK39297 in Patients With Paroxysmal Nocturnal Hemoglobinuria Who Are Naive to Complement Inhibitor Therapy

Who this might be right for
PNH
Haisco Pharmaceutical Group Co., Ltd. 73
Post-approval studies (Phase 4)Study completedNCT02874066
What this trial is testing

PrOD for Non-Cirrhotic Patients With HCV-1b Receiving Hemodialysis

Who this might be right for
Hepatitis Viruses
National Taiwan University Hospital 46
Large-scale testing (Phase 3)Study completedNCT00573001
What this trial is testing

Evaluation of 4 New Simplified Antiretroviral Treatments in Naive HIV-1 Infected Patients in Africa (ANRS 12115 DAYANA)

Who this might be right for
HIV Infections
French National Agency for Research on AIDS and Viral Hepatitis 120
Testing effectiveness (Phase 2)Study completedNCT01221298
What this trial is testing

A Pilot Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of ABT-450 With Ritonavir (ABT-450/r) Dosed in Combination With ABT-072 and Ribavirin (RBV)

Who this might be right for
Hepatitis CHCVChronic Hepatitis C Infection+1 more
AbbVie (prior sponsor, Abbott) 11
Early research (Phase 1)Study completedNCT01675765
What this trial is testing

Safety and Efficacy of Listeria in Combination With Chemotherapy as Front-line Treatment for Malignant Pleural Mesothelioma

Who this might be right for
Malignant Pleural Mesothelioma
Aduro Biotech, Inc. 60
Testing effectiveness (Phase 2)WithdrawnNCT03608501
What this trial is testing

Ixazomib, Thalidomide and Dexamethasone in Newly Diagnosed and Treatment-naive Multiple Myeloma (MM) Participants Non-eligible for Autologous Stem-cell Transplantation

Who this might be right for
Multiple Myeloma
Takeda
Load More Results